Stay updated with breaking news from Ben Brahim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TG4001- Results from the interim analysis of the randomized Phase II trial in HPV-positive anogenital cancers to be released in Q4 2022 TG4050 (myvac platform) - New positive Phase I data presented
Strasbourg, France, and Lund, Sweden, June 28, 2022, 8:00 am CEST – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on th...
LUND, SWEDEN / ACCESSWIRE / June 28, 2022 / BioInvent International (STO:BINV)Lund, Sweden - June 28, 2022 - BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused
Transgene’s Combined General Meeting of May 25, 2022 Strasbourg, France, May 25, 2022, 05:45 p.m. CEST – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company’s headquarters (400 boulevard Gonth...
Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard